Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment

Diseases of the Esophagus

Volumn 27, Issue 7, 2014, Pages 685-692

  Shen, H ^a,b   Yang, Y ^a   Xia, S ^b   Rao, B ^b   Zhang, J ^a   Wang, J ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b First Hospital of Nanchang   (China)

Author keywords

ESCC; Hypoxic microenvironment; Migration and invasion; Nrf2

Indexed keywords

BETA ACTIN; GELATINASE A; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; TRANSCRIPTION FACTOR NRF2; CADHERIN; HEME OXYGENASE 1; HIF1A PROTEIN, HUMAN; HMOX1 PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MMP2 PROTEIN, HUMAN; NFE2L2 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ARTICLE; CELL CULTURE; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HYPOXIA; LYMPH NODE METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA CELL; TUMOR MICROENVIRONMENT; WESTERN BLOTTING; WOUND HEALING; ANOXIA; ANTAGONISTS AND INHIBITORS; CELL MOTION; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR INVASION; UPREGULATION;

ANOXIA; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEME OXYGENASE-1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; NF-E2-RELATED FACTOR 2; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR MICROENVIRONMENT; UP-REGULATION;

EID: 84906791717     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/dote.12124     Document Type: Article

References (32)

1. He J, Shao K. The epidemiology, current status of management, challenge and future strategy for esophageal cancer in China. China Oncol 2011; 21 (7): 501-504.
2. Singh A, Misra V, Thimmulappa R K etal. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med 2006; 3 (10): 1865-1876.
3. Taguchi K, Motohashi H, Yamamoto M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 2011; 16 (2): 123-140.
4. Homma S, Ishii Y, Morishima Y etal. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin Cancer Res 2009; 15 (10): 3423-3432.
5. Ohta T, Iijima K, Miyamoto M etal. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res 2008; 68 (5): 1303-1309.
6. Stacy D R, Ely K, Massion P P etal. Increased expression of nuclear factor E2 P45-related factor 2 (NRF2) in head and neck squamous cell carcinomas. Head Neck 2006; 28 (9): 813-818.
7. Gan N, Sun X, Song L. Activation of Nrf2 by microcystin-LR provides advantages for liver cancer cell growth. Chem Res Toxicol 2010; 23 (9): 1477-1484.
8. Shibata T, Kokubu A, Saito S etal. NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer. Neoplasia 2011; 13 (9): 864-U133.
9. Kim T H, Hur E G, Kang S J etal. NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1 alpha. Cancer Res 2011; 71 (6): 2260-2275.
10. Loignon M, Miao W, Hu L etal. Cul3 overexpression depletes Nrf2 in breast cancer and is associated with sensitivity to carcinogens, to oxidative stress, and to chemotherapy. Mol Cancer Ther 2009; 8 (8): 2432-2440.
11. Eades G, Yang M H, Yao Y, Zhang Y S, Zhou Q. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. J Biol Chem 2011; 286 (47): 40725-40733.
12. Kim Y R, Oh J E, Kim M S etal. Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin. J Pathol 2010; 220 (4): 446-451.
13. Mao J-T, Tangsakar E, Shen H etal. Expression and clinical significance of Nrf2 in esophageal squamous cell carcinoma. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2011; 27 (11): 1231-1233.
14. Zhang L, Zhang M, Zhou S, Zhang J, Zhang G. Rnai-mediated silencing of Nrf2 gene expression in esophageal squmous cell carcinoma inhibits tumor growth and increases efficacy of chemotherapy. Ann Oncol 2012; 23: 31-32.
15. Sporn M B, Liby K T. NRF2 and cancer: the good, the bad and the importance of context. Nat Rev Cancer 2012; 12 (8): 564-571.
16. Choi Y K, Kim C-K, Lee H etal. Carbon monoxide promotes VEGF expression by increasing HIF-1 alpha protein level via two distinct mechanisms, translational activation and stabilization of HIF-1 alpha protein. J Biol Chem 2010; 285 (42): 32116-32125.
17. Gong P F, Hu B, Stewart D etal. Cobalt induces heme oxygenase-1 expression by a hypoxia-inducible factor-independent mechanism in Chinese hamster ovary cells - regulation by Nrf2 and MafG transcription factors. J Biol Chem 2001; 276 (29): 27018-27025.
18. Dulak J, Jozkowicz A, Foresti R etal. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal 2002; 4 (2): 229-240.
19. Finger E C, Giaccia A J. Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev 2010; 29 (2): 285-293.
20. Lisanti M P, Martinez-Outschoorn U E, Chiavarina B etal. Understanding the 'lethal' drivers of tumor-stroma co-evolution emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment. Cancer Biol Ther 2010; 10 (6): 537-542.
21. Kaelin W G Jr, Ratcliffe P J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008; 30 (4): 393-402.
22. Kim Y-J, Ahn J-Y, Liang P, Ip C, Zhang Y, Park Y-M. Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology. Cancer Res 2007; 67 (2): 546-554.
23. Malec V, Gottschald O R, Li S, Rose F, Seeger W, Haenze J. HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells. Free Radic Biol Med 2010; 48 (12): 1626-1635.
24. Lau A, Villeneuve N F, Sun Z, Wong P K, Zhang D D. Dual roles of Nrf2 in cancer. Pharmacol Res 2008; 58 (5-6): 262-270.
25. Lu X, Kang Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res 2010; 16 (24): 5928-5935.
26. Shen H, Zhou S, Wang J. The paradoxical role of Nrf2 in tumor biology. Crit Rev Eukaryot Gene Expr 2013; 23 (1): 37-47.
27. Woessner J F. Matrix metalloproteinases and their inhibitors in connective-tissue remodeling. FASEB J 1991; 5 (8): 2145-2154.
28. Wang X, Lu N, Niu B, Chen X, Xie J, Cheng N. Overexpression of Aurora-A enhances invasion and matrix metalloproteinase-2 expression in esophageal squamous cell carcinoma cells. Mol Cancer Res 2012; 10 (5): 588-596.
29. Kalluri R, Weinberg R A. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119 (6): 1420-1428.
30. Friedl P, Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011; 147 (5): 992-1009.
31. Le Bras G F, Allison G L, Richards N F, Ansari S S, Washington M K, Andl C D. CD44 upregulation in E-cadherin-negative esophageal cancers results in cell invasion. PLoS One 2011; 6 (11): e27063.
32. Chen Y, Lu Y, Lu C, Zhang L. Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1 alpha expression. Pathol Oncol Res 2009; 15 (3): 487-493.